Status:
COMPLETED
Lung Scintigraphy for Pulmonary Embolism Diagnosis in COVID-19 Patients.
Lead Sponsor:
University Hospital, Brest
Conditions:
Pulmonary Embolism
COVID-19
Eligibility:
All Genders
18-99 years
Brief Summary
A frequent complication of COVID-19 disease is pulmonary embolism (PE). Lung ventilation/perfusion (V/P) scintigraphy is a well-established test for PE diagnosis. The test is interpreted based on the...
Eligibility Criteria
Inclusion
- Patients with suspected COVID-19 disease
- Referred for lung scintigraphy for suspected acute PE
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty by an administrative or judicial decision
- Inability or refuse to give consent
Key Trial Info
Start Date :
April 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT05353608
Start Date
April 30 2021
End Date
May 31 2021
Last Update
August 9 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609
2
Cnetre Jean-Perrin
Clermont-Ferrand, France